Express Scripts Inc.  (ESRX) Trade Now »     Rate ESRX  -  Discuss ESRX  -  Add to Watch List        

Health Cost Containment Index: Expanding into India, Impax Labs Set to Re-List

The ETF Innovators [ETFI] Global Healthcare Cost Containment Index profiled in the accompanying table is updated and expanded to include more companies from my recent Analysis of Generic Drug Companies from India . The index is structured to include companies with market caps between $150M-$60B, which are involved in producing generic healthcare products such as generic drugs and pharmacy benefit managers which do not have retail store and insurance components.

The Top 10

A New Global Healthcare Composite Index

The accompanying table [click to enlarge or download] presents the top five rated companies with market caps of at least $250M from each of the 10 new healthcare indexes developed by ETF Innovators [ETFI] from a database of about 500 companies worldwide. The ETFI Global Healthcare Sector PerformIdex consists of 50 top rated companies on an equal weight basis from each of the 10 new healthcare indexes as an alternative strategy to existing health composite ETFs with highly correlated returns and over-weight exposure to th

A New Index of Healthcare Cost Containment Companies

The ETF Innovators [ETFI] Global Healthcare Cost Containment Index profiled in the accompanying table includes companies with market caps over $250M which are involved in the following two segments of the healthcare sector with the common theme of reducing healthcare costs and insurance premiums for consumers, employers, and third-party payers such as the government (through Medicare recipients) and insurance companies.

Generic Healthcare Products: This category includes generic prescription a

With all the talk of the crash of commodities and resurgence of the US dollar, it is easy to forget key growth companies that have held up well in this volatile environment. As investors flood into many of the financials, it has been easy to forget some of the new healthcare companies.

Healthcare changes have been sweeping through as Medicare continues to cut reimbursement. These cuts place pressure on companies to lower costs as they see their margins cut. Pharmacy benefits managers seem well placed going forward. Not only has this group shown resiliance in a tough market environment, b

First the market - we continue to cling in a tiny range... can't get over that S&P 1400 level no matter what.<!--more--> All week everyone sits on their hands and waits for the Gods from D.C. to tell us what they do with the peons... we expect 25 basis points and then statements saying balances are risked, we care about inflation blah blah. Or maybe even no cut. Either way it doesn't matter much - these are long term situations yet not a trader on Wall Street can hit buy or sell this week until they see the action.

This has to be the most telegraphed "weare stopping after this meeting" I've